Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1272-1284
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1272
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1272
Clinical stages | Patients, n = 80 | CA 19-9 | CEA | CA 125 | CA 242 |
I | 15 (18.6) | 10 (66.7) | 1 (6.7) | 5 (33.3) | 13 (86.7) |
IIA | 13 (16.3) | 12 (92.3) | 1 (7.7) | 5 (38.5) | 12 (92.3) |
IIB | 4 (5.0) | 4 (100.0) | 0 | 2 (50.0) | 4 (100.0) |
IIIA | 4 (5.0) | 4 (100.0) | 0 | 2 (50.0) | 4 (100.0) |
IIIB | 44 (55.0) | 27 (61.3) | 8 (18.1) | 17 (38.6) | 36 (81.8) |
- Citation: Sinha SR, Prakash P, Singh RK, Sinha DK. Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World J Gastrointest Surg 2022; 14(11): 1272-1284
- URL: https://www.wjgnet.com/1948-9366/full/v14/i11/1272.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i11.1272